#BEGIN_DRUGCARD DB03543

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C12H18NO9P

# Chemical_IUPAC_Name:
2-{[(2S,3R,4R)-2,3,4-trihydroxy-5-(phosphonooxy)pentyl]amino}benzoic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
1-(O-Carboxy-Phenylamino)-1-Deoxy-D-Ribulose-5-Phosphate

# HET_ID:
137

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C12H18NO9P/c14-9(11(16)10(15)6-22-23(19,20)21)5-13-8-4-2-1-3-7(8)12(17)18/h1-4,9-11,13-16H,5-6H2,(H,17,18)(H2,19,20,21)/t9-,10+,11+/m0/s1

# InChI_Key:
InChIKey=AULMJMUNCOBRHC-HBNTYKKESA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
3543

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
351.2464

# Molecular_Weight_Mono:
351.071917691

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1LBF

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-1.2

# Predicted_LogS:
-2.2

# Predicted_Water_Solubility:
2.29e+00 g/l

# Primary_Accession_No:
DB03543

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
46936710

# PubChem_Substance_ID:
46507680

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT00024

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
O[C@@H](CNC1=CC=CC=C1C(O)=O)[C@@H](O)[C@H](O)COP(O)(O)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:22:22 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
X92729

# Drug_Target_1_GenBank_ID_Protein:
3980232

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
trpF

# Drug_Target_1_Gene_Sequence:
>618 bp
ATGGTCAGAGTGAAAATCTGCGGGATAACGAACCTGGAAGATGCACTGTTTTCTGTGGAG
AGTGGTGCTGACGCTGTGGGATTCGTTTTCTATCCTAAGAGCAAAAGGTACATCTCTCCT
GAGGATGCCAGGAGGATTTCTGTTGAATTACCTCCTTTCGTTTTTCGTGTGGGGGTCTTT
GTGAACGAAGAACCAGAAAAGATTCTGGATGTGGCCTCTTATGTTCAGCTGAACGCGGTC
CAGCTACATGGAGAAGAACCGATCGAACTGTGCAGAAAAATAGCGGAGAGAATCCTGGTG
ATAAAAGCAGTTGGAGTTTCGAACGAAAGGGATATGGAACGTGCTTTGAATTACAGGGAA
TTTCCGATTCTTCTCGATACGAAGACACCGGAGTATGGAGGAAGCGGAAAAACGTTCGAC
TGGTCTCTGATCCTCCCGTACAGGGACCGGTTCAGGTATCTCGTGCTATCGGGAGGTTTG
AATCCTGAGAACGTCAGAAGTGCGATAGACGTGGTTAGACCTTTCGCGGTGGATGTGTCT
TCCGGTGTTGAGGCCTTTCCGGGAAAGAAAGATCACGATTCAATAAAGATGTTCATTAAA
AATGCAAAGGGGTTGTGA

# Drug_Target_1_General_Function:
Involved in phosphoribosylanthranilate isomerase activity

# Drug_Target_1_General_References:
10360571	Nelson KE, Clayton RA, Gill SR, Gwinn ML, Dodson RJ, Haft DH, Hickey EK, Peterson JD, Nelson WC, Ketchum KA, McDonald L, Utterback TR, Malek JA, Linher KD, Garrett MM, Stewart AM, Cotton MD, Pratt MS, Phillips CA, Richardson D, Heidelberg J, Sutton GG, Fleischmann RD, Eisen JA, White O, Salzberg SL, Smith HO, Venter JC, Fraser CM: Evidence for lateral gene transfer between Archaea and bacteria from genome sequence of Thermotoga maritima. Nature. 1999 May 27;399(6734):323-9.
7556082	Sterner R, Dahm A, Darimont B, Ivens A, Liebl W, Kirschner K: (Beta alpha)8-barrel proteins of tryptophan biosynthesis in the hyperthermophile Thermotoga maritima. EMBO J. 1995 Sep 15;14(18):4395-402.
9166771	Hennig M, Sterner R, Kirschner K, Jansonius JN: Crystal structure at 2.0 A resolution of phosphoribosyl anthranilate isomerase from the hyperthermophile Thermotoga maritima: possible determinants of protein stability. Biochemistry. 1997 May 20;36(20):6009-16.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2820

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
23041

# Drug_Target_1_Name:
N-(5'-phosphoribosyl)anthranilate isomerase

# Drug_Target_1_Number_of_Residues:
205

# Drug_Target_1_PDB_ID:
1LBM

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00697	PRAI

# Drug_Target_1_Protein_Sequence:
>N-(5'-phosphoribosyl)anthranilate isomerase
MVRVKICGITNLEDALFSVESGADAVGFVFYPKSKRYISPEDARRISVELPPFVFRVGVF
VNEEPEKILDVASYVQLNAVQLHGEEPIELCRKIAERILVIKAVGVSNERDMERALNYRE
FPILLDTKTPEYGGSGKTFDWSLILPYRDRFRYLVLSGGLNPENVRSAIDVVRPFAVDVS
SGVEAFPGKKDHDSIKMFIKNAKGL

# Drug_Target_1_Reaction:
N-(5-phospho-beta-D-ribosyl)anthranilate = 1-(2-carboxyphenylamino)-1-deoxy-D-ribulose 5-phosphate

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
N-(5-phospho-beta-D-ribosyl)anthranilate = 1- (2-carboxyphenylamino)-1-deoxy-D-ribulose 5-phosphate

# Drug_Target_1_SwissProt_ID:
Q56320

# Drug_Target_1_SwissProt_Name:
TRPF_THEMA

# Drug_Target_1_Synonyms:
EC 5.3.1.24
PRAI

# Drug_Target_1_Theoretical_pI:
6.55

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Not Available

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
V00366

# Drug_Target_2_GenBank_ID_Protein:
43192

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
trpC

# Drug_Target_2_Gene_Sequence:
>1359 bp
ATGCAAACCGTTTTAGCGAAAATCGTCGCAGACAAGGCGATTTGGGTAGAAGCCCGCAAA
CAGCAGCAACCGCTGGCCAGTTTTCAGAATGAGGTTCAGCCGAGCACGCGACATTTTTAT
GATGCGCTACAGGGTGCGCGCACGGCGTTTATTCTGGAGTGCAAGAAAGCGTCGCCGTCA
AAAGGCGTGATCCGTGATGATTTCGATCCAGCACGCATTGCCGCCATTTATAAACATTAC
GCTTCGGCAATTTCGGTGCTGACTGATGAGAAATATTTCAGGGGTAGCTTTAATTTCCTC
CCCATCGTCAGCCAAATCGCCCCGCAGCCGATTTTATGTAAAGACTTCATTATCGACCCT
TACCAGATCTATCTGGCGCGCTATTACCAGGCCGATGCCTGCTTATTAATGCTTTCAGTA
CTGGATGACGACCAATATCGCCAGCTTGCCGCCGTCGCTCACAGTCTGGAGATGGGGGTG
CTGACCGAAGTCAGTAATGAAGAGGAACAGGAGCGCGCCATTGCATTGGGAGCAAAGGTC
GTTGGCATCAACAACCGCGATCTGCGTGATTTGTCGATTGATCTCAACCGTACCCGCGAG
CTTGCGCCGAAACTGGGGCACAACGTGACGGTAATCAGCGAATCCGGCATCAATACTTAC
GCTCAGGTGCGCGAGTTAAGCCACTTCGCTAACGGTTTTCTGATTGGTTCGGCGTTGATG
GCCCATGACGATTTGCACGCCGCCGTGCGCCGGGTGTTGCTGGGTGAGAATAAAGTATGT
GGCCTGACGCGTGGGCAAGATGCTAAAGCAGCTTATGACGCGGGCGCGATTTACGGTGGG
TTGATTTTTGTTGCGACATCACCGCGTTGCGTCAACGTTGAACAGGCGCAGGAAGTGATG
GCTGCGGCACCGTTGCAGTATGTTGGCGTGTTCCGCAATCACGATATTGCCGATGTGGTG
GACAAAGCTAAGGTGTTATCGCTGGTGGCAGTGCAACTGCATGGTAATGAAGAACAGCTG
TATATCGATACGCTGCGTGAAGCTCTGCCAGCACATGTTGCCATCTGGAAAGCATTAAGC
GTCGGTGAAACCCTGCCCGCCCGCGAGTTTCAGCACGTTGATAAATATGTTTTAGACAAC
GGCCAGGGTGGAAGCGGGCAACGTTTTGACTGGTCACTATTAAATGGTCAAACGCTTGGC
AACGTTCTGCTGGCGGGGGGCTTAGGCGCAGATAACTGCGTGGAAGCGGCACAAACCGGC
TGCGCCGGACTTGATTTTAATTCTGCTGTAGAGTCGCAACCGGGCATCAAAGACGCACGT
CTTTTGGCCTCGGTTTTCCAGACGCTGCGCGCATATTAA

# Drug_Target_2_General_Function:
Amino acid transport and metabolism

# Drug_Target_2_General_References:
1738159	Wilmanns M, Priestle JP, Niermann T, Jansonius JN: Three-dimensional structure of the bifunctional enzyme phosphoribosylanthranilate isomerase: indoleglycerolphosphate synthase from Escherichia coli refined at 2.0 A resolution. J Mol Biol. 1992 Jan 20;223(2):477-507.
2184433	Wilmanns M, Schlagenhauf E, Fol B, Jansonius JN: Crystallization and structure solution at 4 A resolution of the recombinant synthase domain of N-(5'-phosphoribosyl)anthranilate isomerase:indole-3-glycerol-phosphate synthase from Escherichia coli complexed to a substrate analogue. Protein Eng. 1990 Jan;3(3):173-80.
6355484	Horowitz H, Van Arsdell J, Platt T: Nucleotide sequence of the trpD and trpC genes of Salmonella typhimurium. J Mol Biol. 1983 Oct 5;169(4):775-97.
7007653	Christie GE, Platt T: Gene structure in the tryptophan operon of Escherichia coli. Nucleotide sequence of trpC and the flanking intercistronic regions. J Mol Biol. 1980 Oct 5;142(4):519-30.
7038627	Yanofsky C, Platt T, Crawford IP, Nichols BP, Christie GE, Horowitz H, VanCleemput M, Wu AM: The complete nucleotide sequence of the tryptophan operon of Escherichia coli. Nucleic Acids Res. 1981 Dec 21;9(24):6647-68.
8095913	Milkman R, Bridges MM: Molecular evolution of the Escherichia coli chromosome. IV. Sequence comparisons. Genetics. 1993 Mar;133(3):455-68.
9097039	Aiba H, Baba T, Hayashi K, Inada T, Isono K, Itoh T, Kasai H, Kashimoto K, Kimura S, Kitakawa M, Kitagawa M, Makino K, Miki T, Mizobuchi K, Mori H, Mori T, Motomura K, Nakade S, Nakamura Y, Nashimoto H, Nishio Y, Oshima T, Saito N, Sampei G, Horiuchi T, et al.: A 570-kb DNA sequence of the Escherichia coli K-12 genome corresponding to the 28.0-40.1 min region on the linkage map. DNA Res. 1996 Dec 31;3(6):363-77.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
2839

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
49362

# Drug_Target_2_Name:
Tryptophan biosynthesis protein trpCF [Includes: Indole-3-glycerol phosphate synthase

# Drug_Target_2_Number_of_Residues:
452

# Drug_Target_2_PDB_ID:
1PII

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF00218	IGPS
PF00697	PRAI

# Drug_Target_2_Protein_Sequence:
>Tryptophan biosynthesis protein trpCF [Includes: Indole-3-glycerol phosphate synthase
MQTVLAKIVADKAIWVEARKQQQPLASFQNEVQPSTRHFYDALQGARTAFILECKKASPS
KGVIRDDFDPARIAAIYKHYASAISVLTDEKYFQGSFNFLPIVSQIAPQPILCKDFIIDP
YQIYLARYYQADACLLMLSVLDDDQYRQLAAVAHSLEMGVLTEVSNEEEQERAIALGAKV
VGINNRDLRDLSIDLNRTRELAPKLGHNVTVISESGINTYAQVRELSHFANGFLIGSALM
AHDDLHAAVRRVLLGENKVCGLTRGQDAKAAYDAGAIYGGLIFVATSPRCVNVEQAQEVM
AAAPLQYVGVFRNHDIADVVDKAKVLSLAAVQLHGNEEQLYIDTLREALPAHVAIWKALS
VGETLPAREFQHVDKYVLDNGQGGSGQRFDWSLLNGQSLGNVLLAGGLGADNCVEAAQTG
CAGLDFNSAVESQPGIKDARLLASVFQTLRAY

# Drug_Target_2_Reaction:
1-(2-carboxyphenylamino)-1-deoxy-D-ribulose 5-phosphate = 1-C-(indol-3-yl)-glycerol 3-phosphate + CO2 + H2O

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
Bifunctional enzyme that catalyzes two sequential steps of tryptophan biosynthetic pathway. The first reaction is catalyzed by the isomerase, coded by the trpF domain; the second reaction is catalyzed by the synthase, coded by the trpC domain

# Drug_Target_2_SwissProt_ID:
P00909

# Drug_Target_2_SwissProt_Name:
TRPC_ECOLI

# Drug_Target_2_Synonyms:
EC 4.1.1.48
IGPS
N-(5'-phospho- ribosyl)anthranilate isomerase;EC 5.3.1.24

# Drug_Target_2_Theoretical_pI:
5.61

# Drug_Target_2_Transmembrane_Regions:
None

#END_DRUGCARD DB03543
